Back
Corporate News
Piramal Pharma’s acquisition of Yapan Bio boosts stake to 74% for roughly Rs 76 crores
18-Aug-2026, 12:58
Piramal Pharma Limited has completed the acquisition of 1,46,400 equity shares of Rs 10 each from existing shareholders of Yapan Bio Private Limited for approximately Rs 76 crores, increasing its stake in the contract development and manufacturing organization from 33.33% to 74.00%, thereby making Yapan a subsidiary of Piramal Pharma.
Piramal Pharma Limited has completed the acquisition of 1,46,400 equity shares of Rs 10 each from existing shareholders of Yapan Bio Private Limited for approximately Rs 76 crores, increasing its stake in the contract development and manufacturing organization from 33.33% to 74.00%, thereby making Yapan a subsidiary of Piramal Pharma.